Observations placeholder

Fluocinonide (Fluonex, Lidex, Lidex-E, Lonide, Lyderm, and Vanos is a potent glucocorticoid used topically as an anti-inflammatory agent for the treatment of skin disorders such as eczema and seborrhoeic dermatitis.

Fluocinonide ranks as a "high-potency" (second-highest rank) topical corticosteroid. Minimal amounts should be used for a minimal length of time to avoid the occurrence of adverse effects.

A common potential adverse effect is skin atrophy (thinning of the skin). Systemic absorption of topical corticosteroids can produce reversible hypothalamic-pituitary-adrenal axis (HPA) suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria in some patients.

Fluocinonide should be used with caution when treating children, pregnant women, nursing mothers, and anyone using the medication for longer than two weeks.

On Dec, 21, 2015: 729 people reported to have side effects when taking Fluocinonide. Among them, 3 people (0.27%) have Hallucination.

On Dec, 21, 2015: 729 people reported to have side effects when taking Fluocinonide. Among them, 18 people (2.47%) have Death.

Time on Fluocinonide when people have Death  :

Gender of people who have Death when taking Fluocinonide  :

Female Male Death 31.58%  68.42%